| Dr Nils Charles Westfall, MD | |
|
555 E Broadway Ave Ste 204, Jackson, WY 83001-8640 | |
| (307) 739-4818 | |
| (307) 739-4866 |
| Full Name | Dr Nils Charles Westfall |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 11 Years |
| Location | 555 E Broadway Ave Ste 204, Jackson, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992047682 | NPI | - | NPPES |
| 156592300 | Medicaid | WY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 13186A (Wyoming) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Teton County Hospital District | 4880582295 | 109 |
News Archive
An advisory committee for U.S. Food and Drug Administration meets Friday to review the safety of a popular class of osteoporosis drugs called bisphosphonates amid worry that their long-term use could cause rare fractures of the thighbones and affect the jawbone. The committee will evaluate whether women should temporarily stop using the drugs or use them for only a few years.
Intermittent signaling by steroid hormones can affect the way genes are expressed in rodents, according to research by scientists at the University of Bristol and the National Cancer Institute (NCI), USA. This work has major implications for understanding how steroids work and opens novel avenues for new therapies.
Researchers from Joslin Diabetes Center, using a genome-wide association study, have identified a genetic factor linked to the development of diabetic peripheral neuropathy.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
Nearly a year into the coronavirus disease (COVID-19) pandemic, many countries are easing restrictions to rebuild their economies. At the same time, many industries are trying to return to a new normal, one of which being the cruise sector. Prior to the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19, the cruise industry represented 2% of the worldwide travel and tourism industry.
› Verified 1 days ago
| Entity Name | Teton County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487818605 PECOS PAC ID: 4880582295 Enrollment ID: O20040308000954 |
News Archive
An advisory committee for U.S. Food and Drug Administration meets Friday to review the safety of a popular class of osteoporosis drugs called bisphosphonates amid worry that their long-term use could cause rare fractures of the thighbones and affect the jawbone. The committee will evaluate whether women should temporarily stop using the drugs or use them for only a few years.
Intermittent signaling by steroid hormones can affect the way genes are expressed in rodents, according to research by scientists at the University of Bristol and the National Cancer Institute (NCI), USA. This work has major implications for understanding how steroids work and opens novel avenues for new therapies.
Researchers from Joslin Diabetes Center, using a genome-wide association study, have identified a genetic factor linked to the development of diabetic peripheral neuropathy.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
Nearly a year into the coronavirus disease (COVID-19) pandemic, many countries are easing restrictions to rebuild their economies. At the same time, many industries are trying to return to a new normal, one of which being the cruise sector. Prior to the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19, the cruise industry represented 2% of the worldwide travel and tourism industry.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nils Charles Westfall, MD Po Box 428, Jackson, WY 83001-0428 Ph: (307) 739-4818 | Dr Nils Charles Westfall, MD 555 E Broadway Ave Ste 204, Jackson, WY 83001-8640 Ph: (307) 739-4818 |
News Archive
An advisory committee for U.S. Food and Drug Administration meets Friday to review the safety of a popular class of osteoporosis drugs called bisphosphonates amid worry that their long-term use could cause rare fractures of the thighbones and affect the jawbone. The committee will evaluate whether women should temporarily stop using the drugs or use them for only a few years.
Intermittent signaling by steroid hormones can affect the way genes are expressed in rodents, according to research by scientists at the University of Bristol and the National Cancer Institute (NCI), USA. This work has major implications for understanding how steroids work and opens novel avenues for new therapies.
Researchers from Joslin Diabetes Center, using a genome-wide association study, have identified a genetic factor linked to the development of diabetic peripheral neuropathy.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
Nearly a year into the coronavirus disease (COVID-19) pandemic, many countries are easing restrictions to rebuild their economies. At the same time, many industries are trying to return to a new normal, one of which being the cruise sector. Prior to the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19, the cruise industry represented 2% of the worldwide travel and tourism industry.
› Verified 1 days ago
Dr. Catherine Haynes Wuthrich, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2092 Lilac Lane, Jackson, WY 83002 Phone: 651-894-4008 | |
Kathleen M Logan, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 555 E Broadway Ave Ste 204, Jackson, WY 83001 Phone: 307-739-4818 Fax: 888-329-5701 | |
Christopher Andrew Ramsey, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 680 S Cache St Ste 100, Jackson, WY 83001 Phone: 212-518-6718 |